ArticleBMC nephrology2026
Nephrologist follow-up improves outcomes after hospitalization with acute kidney injury.
Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
introductionAcute kidney injury (AKI) is a common medical condition for patients during hospitalization and is associated with long-term sequelae. The incidence of AKI is increasing, whereas in-hospital mortality from the condition is decreasing. We compared outcomes following discharge in patients with AKI between those who received follow-up with nephrologists and those who only received routine follow-up (i.e., follow-up not at the nephrology department). MATERIALS AND
methodsThis retrospective cohort study identified 66,859 AKI survivors with discharge eGFR values of less than 60 mL/min/1.73 m² from January 1, 2004, to June 30, 2019. Patients were categorized by follow-up department after discharge into nephrology and non-nephrology groups during the 6-month exposed period. The clinical outcomes included all-cause death, cardiovascular death, heart failure, readmission with AKI, and new-onset dialysis.
resultsAKI survivors who received 3 years of follow-up at a nephrology department had significantly lower rates of all-cause death (hazard ratio [HR]: 0.91; 95% CI: 0.87 to 0.96), cardiovascular death (HR: 0.82; 95% CI: 0.75 to 0.90), and readmission with AKI (HR: 0.82; 95% CI: 0.77 to 0.87) but higher rates of heart failure (HR: 1.13; 95% CI: 1.05 to 1.21) and new-onset dialysis (HR: 1.67; 95% CI: 1.43 to 1.95) than did those who received routine follow-up at non-nephrology department.
conclusionsFollowing discharge, patients with AKI during hospitalization, especially severe AKI, are at significantly lower risk of all-cause death, cardiovascular death, and readmission with AKI if they receive follow-up at a nephrology department compared with non-nephrology follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.